National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry
New York, NY, Nov. 07, 2025 (GLOBE NEWSWIRE) — Following a challenge submitted by Pfizer, Inc., BBB National Programs' National Advertising Division will refer BridgeBio Pharma Inc. to the relevant government agencies for review and possible enforcement action for failure to participate in the National Advertising Division (NAD) inquiry. Pfizer and BridgeBio sell prescription medication […]